FX1 is a Specific BCL6 Inhibitor for Lymphoma Research
Bcl-6 (B-cell lymphoma 6) is a protein that in humans is encoded by the BCL6 gene. Mutations in BCL6 can lead to B cell lymphomas because it promotes unchecked B…
Bcl-6 (B-cell lymphoma 6) is a protein that in humans is encoded by the BCL6 gene. Mutations in BCL6 can lead to B cell lymphomas because it promotes unchecked B…
PROTAC has been developed to degrade a wide range of clinically relevant targets. These small-molecule degraders engage both the E3 ligase and the target protein to promote the formation of…
BCL6 (B-cell lymphoma 6 protein) is a transcriptional repressor. Strikingly, this protein plays a key role in the formation and maintenance of germinal centers during the process of antibody affinity…
B cell lymphoma 6 (BCL6) is a transcriptional repressor that interacts with its corepressors BcoR and SMRT. Since this protein-protein interaction (PPI) induces activation and differentiation of B lymphocytes, BCL6…